Previous genome-wide association studies have identified dozens of susceptibility loci for
sporadic Alzheimer's disease, but few of these loci have been validated in longitudinal …

Objective Genome‐wide association studies (GWAS) have identified over 30 susceptibility
loci associated with Alzheimer's disease (AD). Using AD GWAS data from the International …

The identification of subjects at high risk for Alzheimer's disease is important for prognosis
and early intervention. We investigated the polygenic architecture of Alzheimer's disease …

More than 30 independent single-nucleotide polymorphisms (SNPs) have been associated
with Alzheimer's disease (AD) risk by genome-wide association studies (GWAS) in …

Objective Alzheimer disease (AD) is the most common form of dementia and is responsible
for a huge and growing health care burden in the developed and developing world. The …

The risk of Alzheimer's disease (AD) is strongly determined by genetic factors and recent
genome-wide association studies (GWAS) have identified several genes for the disease risk …

Genome-wide association studies (GWASs) have revealed a plethora of putative
susceptibility genes for Alzheimer's disease (AD). With the sole exception of the APOE gene …

Background Genome-wide association studies have identified more than 30 Alzheimer's
disease (AD) risk genes, although the detailed mechanism through which all these genes …

Linkage studies, candidate gene and whole-genome association studies have resulted in a
tremendous amount of putative risk genes for Alzheimer's disease (AD). Yet, besides the …

More than 20 genetic loci have been associated with risk for Alzheimer's disease (AD), but
reported genome-wide significant loci do not account for all the estimated heritability and …